Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 15:5:1213546.
doi: 10.3389/frph.2023.1213546. eCollection 2023.

Genetic counseling for pre-implantation genetic testing of monogenic disorders (PGT-M)

Affiliations
Review

Genetic counseling for pre-implantation genetic testing of monogenic disorders (PGT-M)

Firuza Parikh et al. Front Reprod Health. .

Abstract

Pre-implantation genetic testing (PGT) is a vital tool in preventing chromosomal aneuploidies and other genetic disorders including those that are monogenic in origin. It is performed on embryos created by intracytoplasmic sperm injection (ICSI). Genetic counseling in the area of assisted reproductive technology (ART) has also evolved along with PGT and is considered an essential and integral part of Reproductive Medicine. While PGT has the potential to prevent future progeny from being affected by genetic conditions, genetic counseling helps couples understand and adapt to the medical, psychological, familial and social implications of the genetic contribution to disease. Genetic counseling is particularly helpful for couples with recurrent miscarriages, advanced maternal age, a partner with a chromosome translocation or inversion, those in a consanguineous marriage, and those using donor gametes. Partners with a family history of genetic conditions including hereditary cancer, late onset neurological diseases and with a carrier status for monogenic disorders can benefit from genetic counseling when undergoing PGT for monogenic disorders (PGT-M). Genetic counseling for PGT is useful in cases of Mendelian disorders, autosomal dominant and recessive conditions and sex chromosome linked disorders and for the purposes of utilizing HLA matching technology for creating a savior sibling. It also helps in understanding the importance of PGT in cases of variants of uncertain significance (VUS) and variable penetrance. The possibilities and limitations are discussed in detail during the sessions of genetic counseling.

Keywords: GC for PGT-M; Mendelian disorders; PGT; PGT-M; genetic counseling; monogenic disorders; preimplantation genetic testing.

PubMed Disclaimer

Conflict of interest statement

AU is employed by GeneTech Laboratory, Hyderabad, India. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Genetic diagnostic workflow for PGT-M of common known variants in certain disorders.
Figure 2
Figure 2
Genetic diagnostic workflow for PGT-M of autosomal dominant conditions.
Figure 3
Figure 3
Genetic diagnostic workflow for PGT-M of autosomal recessive conditions.
Figure 4
Figure 4
Genetic diagnostic workflow for PGT-M of X-linked recessive conditions.
Figure 5
Figure 5
Genetic diagnostic workflow for PGT-M of X-linked dominant conditions.
Figure 6
Figure 6
Summary of end to end genetic counseling work flow for PGT-M.

Similar articles

Cited by

References

    1. Parikh FR, Athalye AS, Kulkarni DK, Sanap RR, Dhumal SB, Warang DJ, et al. Evolution and utility of preimplantation genetic testing for monogenic disorders in assisted reproduction—a narrative review. J Hum Reprod Sci. (2021) 14:329–39. 10.4103/jhrs.jhrs_148_21 - DOI - PMC - PubMed
    1. Epstein CJ, Childs B, Fraser FC, McKusick VA, Miller JR, Motulsky AG, et al. Genetic counseling. Am J Hum Genet. (1975) 27:240–2. PMCID: ; PMID: - PubMed
    1. Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Strecker MN, et al. A new definition of genetic counseling: national society of genetic counselors’ task force report. J Genet Couns. (2006) 15:77–83. 10.1007/s10897-005-9014-3 - DOI - PubMed
    1. Monk M, Muggleton-Harris AL, Rawlings E, Whittingham DG. Pre-implantation diagnosis of HPRT-deficient male and carrier female mouse embryos by trophectoderm biopsy. Hum Reprod. (1988) 3:377–81. 10.1093/oxfordjournals.humrep.a136711 - DOI - PubMed
    1. Scott RT, Jr, Upham KM, Forman EJ, Zhao T, Treff NR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril. (2013) 100:624–30. 10.1016/j.fertnstert.2013.04.039 - DOI - PubMed